CAS 865854-05-3: Tideglusib

Formula: C₁₉H₁₄N₂O₂S

InChI: InChI=1S/C19H14N2O2S/c22-18-20(13-14-7-2-1-3-8-14)19(23)24-21(18)17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2

InChI key: InChIKey=PMJIHLSCWIDGMD-UHFFFAOYSA-N

SMILES: O=C1SN(C(=O)N1CC=2C=CC=CC2)C3=CC=CC=4C=CC=CC43

Tideglusib

CAS: 865854-05-3

• Formula: C₁₉H₁₄N₂O₂S
• Purity: 98%
• Color and Shape: Solid
• Molecular weight: 334.3917

Tideglusib

CAS: 865854-05-3

• Purity: 98.89%
• Molecular weight: 334.39g/mol

Tideglusib

CAS: 865854-05-3

• Purity: 98%
• Molecular weight: 334.39g/mol

Tideglusib

CAS: 865854-05-3

Tideglusib (NP031112), a non-ATP competitive inhibitor of glycogen synthase kinase 3 (GSK-3), is with anti-inflammatory …

• Formula: C₁₉H₁₄N₂O₂S
• Purity: 98.40% - 99.35%
• Color and Shape: Solid
• Molecular weight: 334.39

Tideglusib

CAS: 865854-05-3

• Purity: 98.0%
• Color and Shape: Solid
• Molecular weight: 334.3900146484375

Tideglusib

CAS: 865854-05-3

An irreversible GSK-3β inhibitor that reduces phosphorylation of tau proteins, protects from neuronal loss and …

• Formula: C₁₉H₁₄N₂O₂S
• Purity: Min. 95%
• Color and Shape: White To Off-White Solid
• Molecular weight: 334.39 g/mol

Tideglusib (benzyl-d7)

CAS: 865854-05-3

Applications Tideglusib (benzyl-d7) is deuterium labelled form of Tideglusib (T438700), which is used in the …

• Formula: C₁₉D₇H₇N₂O₂S
• Color and Shape: Neat
• Molecular weight: 341.435

Tideglusib

CAS: 865854-05-3

Applications Tideglusib is used in the treatment of brain atrophy, and movement disorder issues. References …

• Formula: C₁₉H₁₄N₂O₂S
• Color and Shape: Neat
• Molecular weight: 334.39

Tideglusib (naphthyl-d7)

CAS: 865854-05-3

Applications Tideglusib (naphthyl-d7) is deuterium labelled form of Tideglusib (T438700), which is used in the …

• Formula: C₁₉H₇D₇N₂O₂S
• Color and Shape: Neat
• Molecular weight: 341.43